New York | The American company Moderna's vaccine is 94 percent effective in protecting patients. The company claimed on Monday that this vaccine can be safe for 30 days in two to eight degree Celsius temperatures.
A week ago, a statement released by the vaccine manufacturer Pfizer revealed that it would face challenges in its storage and transportation.
America's top infectious diseases specialist Anthony Fausi called the modern results effective. Fauci said the US could begin vaccinating its most vulnerable populations by December.
American company Moderna said that it can be protected for up to six months in a temperature of minus 20 degrees Celsius (minus four Fahrenheit).
Apart from this, after removing the vaccine from the refrigerator, it can remain in the right condition at room temperature for 12 hours.
There are 30,000 volunteers associated with the Moderna vaccine created in collaboration with the National Institutes of Health.
A week ago, American-based company Pfizer and its partner Germany's BioNetec claimed more than 90 percent effective vaccine.
At the same time, the effect of the Sputnik V vaccine of the Research Center of Russia has been claimed to be 92 percent. Another US pharmaceutical company, Johnson & Johnson, has started a third-phase trial of two doses of its vaccine to prevent Kovid-19.
Production of the vaccine developed in Oxford has started in Australia.
Vaccine manufacturer Bharat Biotech announced in India that it has begun Phase III trials of Kovacin, India's first indigenous vaccine for Kovid-19. It is being operated in association with the Indian Council of Medical Research (ICMR). The test is being done in 22 institutions in India, including New Delhi AIIMS and Guru Tegh Bahadur Hospital.
.jpeg)
.jpeg)
Posts
